10 results on '"Qiao, Chun"'
Search Results
2. 98% IGHV gene identity is the optimal cutoff to dichotomize the prognosis of Chinese patients with chronic lymphocytic leukemia.
- Author
-
Shi, Ke, Sun, Qian, Qiao, Chun, Zhu, Huayuan, Wang, Li, Wu, Jiazhu, Wang, Lili, Fu, Jianxin, Young, Ken H., Fan, Lei, Xia, Yi, Xu, Wei, and Li, Jianyong
- Subjects
CHRONIC lymphocytic leukemia ,IMMUNOGLOBULIN heavy chains ,PROGNOSIS ,GENETIC markers ,MULTIVARIATE analysis ,BRAF genes ,LYMPHOCYTOSIS - Abstract
Immunoglobulin heavy chain variable region (IGHV) mutational status has been an important prognostic factor for chronic lymphocytic leukemia (CLL) for decades. Patients with unmutated IGHV (≥98% identity to the germline sequence) have inferior prognosis and tend to carry unfavorable genetic markers compared to those with mutated IGHV (<98% identity to the germline sequence). However, 98% as the cutoff for IGHV mutational status is a mathematical choice and remains controversial. We have previously reported distinct IGHV repertoire features between Chinese and western CLL populations. Here, we retrospectively studied 595 Chinese CLL patients to determine the best cutoff value for IGHV in Chinese CLL population. Using 1% as the interval for IGHV identity, we divided the studied cohort into seven subgroups from 95% to 100%. Briefer time to first treatment (TTFT) and overall survival (OS) were observed in cases with ≥98% compared to those with <98%, while the differences were obscure within subgroups ≥98% (98%‐98.99%, 99%‐99.99%, and 100%) and <98% (<94.99%, 95%‐95.99%, 96%‐96.99%, and 97%‐97.99%). Multivariate analysis confirmed the independent prognostic value of 98% being the cutoff for IGHV identity in terms of both TTFT and OS. All the prognostic factors, including del(17p13), del(11q22.3), TP53 mutation, MYD88 mutation, NOTCH1 mutation, SF3B1 mutation, CD38, ZAP‐70, Binet staging, gender, and β2‐microglobulin, were significantly different in distribution between group <98% and group ≥98%, but not among subgroups 98%‐98.99%, 99%‐99.99%, and 100%. In conclusion, 98% is the optimal cutoff of IGHV identity for the prognosis evaluation of Chinese CLL patients. [ABSTRACT FROM AUTHOR]
- Published
- 2020
- Full Text
- View/download PDF
3. <italic>NOTCH1</italic> mutation and its prognostic significance in Chinese chronic lymphocytic leukemia: a retrospective study of 317 cases.
- Author
-
Zou, Yixin, Fan, Lei, Xia, Yi, Miao, Yi, Wu, Wei, Cao, Lei, Wu, Jiazhu, Zhu, Huayuan, Qiao, Chun, Wang, Li, Xu, Wei, and Li, Jianyong
- Subjects
LYMPHOCYTIC leukemia ,IMMUNOGLOBULINS ,GENETIC mutation ,GLUTAMIC acid ,PROGNOSIS - Abstract
Abstract: The proto‐oncogene
NOTCH1 is frequently mutated in around 10% of patients with chronic lymphocytic leukemia (CLL). This study analyzedNOTCH1 mutation status of 317 Chinese patients with CLL by Sanger sequencing. The frequencies ofNOTCH1 mutation in the PEST (proline (P), glutamic acid (E), serine (S), threonine (T)‐rich protein sequence) domain and the 3′ untranslated regions (UTR) were 8.2% and 0.9%, with the most frequent mutation being c.7541_7542delCT and c.*371A>G, respectively. Clinical and biological associations were determined includingNOTCH1 mutations with advanced stage (Binet stage,P = 0.010), unmutated immunoglobulin heavy‐chain variable region (IGHV ) gene (P < 0.001) and trisomy 12 (+12) (P = 0.014).NOTCH1‐ mutated patients had lower CD20 expression intensity thanNOTCH1‐ unmutated patients (P = 0.029). In addition,NOTCH1 ‐mutated patients had shorter overall survival (OS) (P = 0.002) and treatment‐free survival (TFS) (P = 0.002) thanNOTCH1 ‐unmutated patients, especially for patients withNOTCH1 c.7541_7542delCT and/or c.*371A>G mutations. Patients with both mutatedNOTCH1 and unmutatedIGHV had shorter OS (P < 0.001) and TFS (P < 0.001) than those with unmutatedNOTCH1 or mutatedIGHV . These data provide a comprehensive view of the clinical relevance and prognostic impact ofNOTCH1 mutations on Chinese patients with CLL. [ABSTRACT FROM AUTHOR]- Published
- 2018
- Full Text
- View/download PDF
4. Spectrum and immunophenotyping of 653 patients with B-cell chronic lymphoproliferative disorders in China: A single-centre analysis.
- Author
-
Miao, Yi, Cao, Lei, Sun, Qian, Li, Xiao‐Tong, Wang, Yan, Qiao, Chun, Wang, Li, Wang, Rong, Qiu, Hai‐Rong, Xu, Wei, Li, Jian‐Yong, Wu, Yu‐Jie, Fan, Lei, Li, Xiao-Tong, Qiu, Hai-Rong, Li, Jian-Yong, and Wu, Yu-Jie
- Subjects
CHRONIC lymphocytic leukemia ,IMMUNOPHENOTYPING ,RETROSPECTIVE studies - Abstract
The incidence of B-cell chronic lymphoproliferative disorders (B-CLPDs) is significantly lower in China than that in western countries. There have been studies involving small cohorts with conflicting results regarding the spectrum of B-CLPDs in China, and the types and immunophenotyping of B-CLPDs in China remain largely unexplored. We conducted a retrospective analysis of 653 cases of B-CLPDs seen in our centre from 2011 to 2015. Four-colour flow cytometry was used to determine the expression of each immunological marker, and the diagnostic values of the immunological markers were also investigated. Chronic lymphocytic leukaemia (CLL) was the most common type of B-CLPD, which was consistent with that in west countries. However, the proportions of CLL (55.9%), follicular lymphoma (2.6%), and hairy cell leukaemia (0.2%) were lower, while the proportion of lymphoplasmacytic lymphoma/WaldenstrÖm macroglobulinaemia (5.4%) was higher in China, as compared with western countries. With respect to immunophenotypic characteristics, CD23 (31.7%) was more frequently expressed in mantle cell lymphoma (MCL) in our cohort than that in western countries. Immunophenotyping was useful in differentiating MCL from CLL or B-cell prolymphocytic leukaemia and lymphoplasmacytic lymphoma/WaldenstrÖm macroglobulinaemia from splenic marginal zone lymphoma. CD200 was of better diagnostic performance (accuracy: 94.6%) in differentiating CLL from MCL compared with CD23 (accuracy: 93.3%). Some cases of B-CPLDs, however, had no definite diagnoses, which were diagnosed as CD5+ B-CPLDs unclassified (7.7%) and CD5- B-CPLDs unclassified (15.8%). This is the largest study that systematically explores the spectrum and immunophenotyping of B-CLPDs in Asia, confirming that spectrum of B-CLPDs in China was different from that in western countries. The immunophenotypic features of B-CLPDs were similar between China and western countries, although a few disparities exist. Cases with no definite diagnoses warrant further studies in the future. [ABSTRACT FROM AUTHOR]
- Published
- 2018
- Full Text
- View/download PDF
5. Polymorphisms and haplotypes in multidrug resistance 1 gene are not associated with chronic lymphocytic leukemia susceptibility and prognostic parameters of chronic lymphocytic leukemia in Chinese population.
- Author
-
Dong, Hua-Jie, Miao, Kou-Rong, Qiao, Chun, Zhuang, Yun, Shen, Wen-Yi, Hong, Ming, Fan, Lei, Liu, Peng, XU, Wei, and Li, Jian-Yong
- Subjects
CHRONIC lymphocytic leukemia ,GENETIC polymorphisms ,MULTIDRUG resistance ,HUMAN cytogenetics ,GLYCOPROTEINS ,POLYMERASE chain reaction ,IMMUNOGLOBULINS ,B cells ,GENETICS - Abstract
The human multidrug resistance (MDR1, ABCB1) gene encodes P-glycoprotein (P-gp), which affects the pharmacokinetics of many drugs. Here, we investigated whether common MDR1 single nucleotide polymorphisms (SNPs) (C1236T, C3435T, and G2677T/A) affect predisposition to chronic lymphocytic leukemia (CLL). Genotyping was performed in 150 patients with CLL and 117 controls using polymerase chain reaction (PCR)-based assays. Haplotypes were inferred using the PHASE algorithm. We found comparable allele and genotype frequencies among patients with CLL and controls. Moreover, patient and control groups did not differ regarding MDR1 haplotype distribution ( p == 0.97). Furthermore, no correlation was shown between the MDR1 1236, 3435, or 2677 genotypes and Binet stage, unmutated immunoglobulin heavy-chain variable region (IGHV) status, CD38 expression, ZAP-70 expression, and p53 deletion. In conclusion, our results do not support a major influence of MDR1 variants on the risk of CLL, and these genomic polymorphisms are not associated with clinical prognostic factors in Chinese patients with CLL. [ABSTRACT FROM AUTHOR]
- Published
- 2011
- Full Text
- View/download PDF
6. The negative prognostic significance of positive direct antiglobulin test in Chinese patients with chronic lymphocytic leukemia.
- Author
-
Xu, Wei, Li, Jian-Yong, Miao, Kou-Rong, Cao, Xin, Liu, Qiong, Fan, Lei, Qiao, Chun, and Wu, Yu-Jie
- Subjects
CHRONIC lymphocytic leukemia diagnosis ,COOMBS' test ,CHRONIC diseases ,MEDICAL care - Abstract
Chronic lymphocytic leukemia (CLL) is the most common type of adult leukemia in the Western countries, however, it is infrequent in the Eastern countries. The direct antiglobulin test (DAT) may be positive at some time during the disease course of CLL. The aim of this study was to explore the prognostic impact of positive DAT at diagnosis in Chinese patients with CLL. In 123 Chinese patients with CLL, 34 (27.6%) patients presented with a positive DAT at diagnosis. However only 12 patients (9.8%) with a positive DAT developed autoimmune hemolytic anemia (AHA). According to the correlation analysis, advanced Binet stage (p < 0.001), high level of serum lactate dehydrogenase (LDH) (p = 0.003) and β2-microglobulin (β2-M) (p = 0.011), unmutated immunoglobulin heavy chain variable gene status (p < 0.001), positive ZAP-70 (p = 0.012), and trisomy 12 cytogenetic aberration (p = 0.004) emerged as factors significantly related to the occurrence of DAT-positive. Patients with positive DAT had significantly shorter survival times than patients with negative DAT (p = 0.009). Five-year OS percentages of DAT-positivity and DAT-negative patients were 72.8% and 97.5%, respectively. It was showed that DAT status might be applied for the assessment of prognosis in patients with CLL. [ABSTRACT FROM AUTHOR]
- Published
- 2009
- Full Text
- View/download PDF
7. Enhancing morphological analysis of peripheral blood cells in chronic lymphocytic leukemia with an artificial intelligence-based tool.
- Author
-
Wang, Yan, Liu, Hailing, Wang, Hui, Wu, Yujie, Qiu, Hairong, Qiao, Chun, Cao, Lei, Zhang, Jianfu, Li, Jianyong, Fan, Lei, and Wang, Rong
- Subjects
- *
ARTIFICIAL intelligence , *CHRONIC lymphocytic leukemia , *BLOOD cells , *CONVOLUTIONAL neural networks , *BLOOD testing - Abstract
Real-time monitoring is essential for the management of chronic lymphocytic leukemia (CLL) patients. Utilizing peripheral blood is advantageous due to its affordability and convenience. Existing methods of assessing peripheral blood films have limitations that include lack of automation, dependence on personal experience, and low repeatability and reproducibility. To overcome these challenges, we have designed an artificial intelligence-driven system that provides a clinical perspective to objectively evaluate morphologic features in CLL patients' blood cells. Based on our center's CLL dataset, we developed an automated algorithm using a deep convolutional neural network to precisely identify regions of interest on blood films and used the well-established Visual Geometry Group-16 as the encoder to segment cells and extract morphological features. This tool enabled us to extract morphological features of all lymphocytes for subsequent analysis. Our study's lymphocyte identification had a recall of 0.96 and an F1 score of 0.97. Cluster analysis identified three clear, morphological groups of lymphocytes that reflect distinct stages of disease development to some extent. To investigate the longitudinal evolution of lymphocyte, we extracted cellular morphology parameters at various time points from the same patient. The results showed some similar trends to those observed in the aforementioned cluster analysis. Correlation analysis further supports the prognostic potential of cell morphology-based parameters. Our study provides valuable insights and potential avenues for further exploration of lymphocyte dynamics in CLL. Investigating morphological changes may help in determining the optimal timing for intervening with CLL patients, but further research is needed. • An AI-based tool provides objective analysis of peripheral blood film features. • The study shows promising prognostic potential for cell morphology in CLL. • Investigation of morphological changes in lymphocytes aids management of CLL. [ABSTRACT FROM AUTHOR]
- Published
- 2023
- Full Text
- View/download PDF
8. Prognostic significance of serum immunoglobulin paraprotein in patients with chronic lymphocytic leukemia
- Author
-
Xu, Wei, Wang, Yin-Hua, Fan, Lei, Fang, Cheng, Zhu, Dan-Xia, Wang, Dong-Mei, Qiao, Chun, Wu, Yu-Jie, and Li, Jian-Yong
- Subjects
- *
SERUM , *IMMUNOGLOBULINS , *PARAPROTEINEMIA , *CHRONIC lymphocytic leukemia , *BLOOD proteins , *ELECTROPHORESIS , *REGRESSION analysis , *PROGNOSIS - Abstract
Abstract: The aim of this study was to explore the clinical and other associated laboratory features of chronic lymphocytic leukemia (CLL) patients with immunoglobulin (Ig) paraproteinemia. Serum protein electrophoresis (SPE) and immunofixation electrophoresis (IFE) were performed to measure serum Ig paraprotein. The correlations between serum Ig paraprotein and other prognostic factors were analyzed. Univariate and multivariate Cox regression analyses were used to assess associations between survival time and potential risk factors. In 133 Chinese CLL patients, 27 (20.3%) patients occurred Ig paraproteinemia at diagnosis. According to the correlation analysis, advanced Binet stage (r =0.314, P <0.001), direct antiglobulin test (DAT)-positive (r =0.366, P <0.001), high level of serum β2-microglobulin (β2-MG) (r =0.296, P =0.001) and thymidine kinase (TK) 1 (r =0.227, P =0.037), unmutated immunoglobulin heavy chain variable gene (IGHV) status (r =0.284, P =0.002), ZAP-70-positive (r =0.305, P =0.001), CD38-positive (r =0.284, P =0.002), and cytogenetic abnormalities of del(17p13) or del(11q22.3) (r =0.208, P =0.032) emerged as factors significantly related to the occurrence of Ig paraproteinemia. Survival analysis showed that the patients with Ig paraproteinemia had significantly shorter survival times than the patients without serum Ig paraprotein (P =0.013). Binet stage (P =0.028), high levels of lactate dehydrogenase (LDH) (P =0.004), IgG paraproteinemia (P =0.048), IgM paraproteinemia (P =0.001), ZAP-70-positive (P =0.003), DAT-positive (P =0.013), unmutated IGHV status (P =0.009), and del(17p13) (P =0.001) were the adverse factors in determining overall survival (OS). Del(17p13) (P =0.006), ZAP-70 (P =0.030), and IgM paraproteinemia (P =0.040) were the variables strongly associated with OS by multivariate Cox regression analysis. It was showed that serum Ig paraprotein might be applied for the assessment of prognosis in patients with CLL. [Copyright &y& Elsevier]
- Published
- 2011
- Full Text
- View/download PDF
9. Clinical features and outcome of Chinese patients with monoclonal B-cell lymphocytosis
- Author
-
Xu, Wei, Li, Jian-Yong, Wu, Yu-Jie, Cao, Xin, Fan, Lei, Qiao, Chun, Liu, Qiong, Yao, Lin, and Miao, Kou-Rong
- Subjects
- *
B cell lymphoma , *LYMPHOCYTES , *CHINESE people , *CHRONIC lymphocytic leukemia diagnosis , *HEALTH outcome assessment , *COOMBS' test , *CANCER prognosis , *DISEASES ,WESTERN countries - Abstract
Abstract: B-cell chronic lymphocytic leukemia (CLL) is the most common type of adult leukemias in the Western countries, however, infrequent in the Eastern. A diagnosis of CLL requires a count of B-lymphocytes ≥5.0×109/L. Asymptomatic person with <5.0×109/L B-lymphocytes is defined as monoclonal B-cell lymphocytosis (MBL). To compare the clinical characteristics, prognostic factors, and outcome of Chinese patients with MBL and CLL, we present a study from our single centre of 20 patients with MBL and 136 patients with CLL. The factors included: age at diagnosis, gender, direct antiglobulin test (DAT), immunoglobulin heavy chain variable gene (IgHV) mutational status, ZAP-70 protein, CD38 expression level, and molecular cytogenetic aberrations were analyzed in MBL and CLL subgroups. The Kaplan–Meier method was used to construct survival curves, and results were compared using the log-rank test. Patients in the MBL category were slightly older than in the CLL category. There was no significant difference of these clinical and biological characteristics between patients in MBL subgroup and early stage CLL (Binet A). The incidence of positive DAT was significantly increased in CLL patients at Binet B and C, compared with MBL (P =0.036). IgHV gene mutation in MBL is skewed, with more than 92.3% of subjects harbored mutated IgVH genes (P =0.025). The proportion of MBL patients with a 13q14 deletion or trisomy 12 was similar to that of CLL patients. Moreover, markers associated with poor prognosis (deletion of 11q22 or 17p13) in these MBL populations were less than those in Binet B and C CLL patients (P =0.025). No statistically significant differences in ZAP-70 and CD38 status were observed between the MBL and CLL subgroups. During a median follow-up period of 45.5 months, MBL patients had a low probability of progression, with no patients transformed to aggressive non-Hodgkin''s lymphoma or dying of CLL-related causes. The overall survival of MBL was very similar to Binet A CLL, but longer than that of CLL patients at advanced stages (Binet B and C) (P =0.024). Our study demonstrated that a more indolent clinical course and superior clinical outcome for patients with MBL compared to CLL. [Copyright &y& Elsevier]
- Published
- 2009
- Full Text
- View/download PDF
10. Distinctive IgVH gene segments usage and mutation status in Chinese patients with chronic lymphocytic leukemia
- Author
-
Chen, Lijuan, Zhang, Yaping, Zheng, Wenjuan, Wu, Yujie, Qiao, Chun, Fan, Lei, Xu, Wei, and Li, Jianyong
- Subjects
- *
CHRONIC lymphocytic leukemia , *CHRONIC diseases , *GENE expression , *ANEMIA - Abstract
Abstract: Background and objectives: The incidence of chronic lymphocytic leukemia (CLL) in Asian countries is lower than that in the Western ones, where CLL is the most common leukemia. It is a clinically heterogeneous disease, with survival ranging from a few months to decades. The mutation status of the immunoglobulin variable heavy chain (IgVH) gene has significantly improved prediction of the risk for disease progression. We investigated the frequency and mutation status of IgVH gene expression in Chinese patients with CLL. Methods: IgVH gene segments usage and mutation status were investigated by multiplex RT-PCR, and the relationship between IgVH somatic mutation status and the expression of CD38 and ZAP-70 was analyzed in 65 CLL patients. Results: Forty-five (69.2%) patients had mutated IgVH, and 20 (30.8%) had unmutated IgVH. The most frequently expressed VH gene family was found to be VH3 (47.7%) followed by VH4 (40%), VH1 (6.2%), VH2 (4.6%) and VH7 (1.5%), with no expression of VH5 or VH6 gene families. VH1-69 and VH3-21 which commonly overused in Western CLL were very low in our cohort. IgVH gene mutation status was significantly associated with the expression of CD38. Conclusions: The frequency of IgVH gene families indicates significant difference in Chinese CLL patients compared with Western patients, suggesting involvement of ethnic and/or environmental factors in CLL disease initiation. The expression of them may be simple and reliable surrogates for the identification of IgVH mutations. [Copyright &y& Elsevier]
- Published
- 2008
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.